Be Ahead With Economy And Policy Updates
New Delhi: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for
New Jersey: Glenmark Pharmaceuticals Inc., USA (Glenmark) today announced the launch1 of Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial.
Hyderabad: Dr. Reddy’s Laboratories today announced the first-to-market launch of Bosutinib Tablets 400mg, a generic equivalent of Bosulif®, in the United States, expanding
New Delhi: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for
Mumbai: India Ratings and Research (Ind-Ra) believes Indian pharma companies’ strong balance sheets and sub-1x leverage profile (FY26: nearly 0.8x) provide headroom for
New Delhi: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for
New Jersey: Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the launch1 of Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL), Single-Dose Vials.
Gurugram: Antara, India’s most comprehensive senior care ecosystem offering end-to-end solutions across all stages of ageing, has opened an integrative medicine clinic in Gurugram,
Hyderabad, India: NATCO Pharma Limited (BSE: 524816 and NSE: NATCOPHARM) (“NATCO”) and its alliance partner Lupin Limited today announced the approval from the
Hyderabad, India: Granules India Limited announced that its wholly-owned subsidiary on Wednesday, Granules Pharmaceuticals, Inc. (GPI), located in Chantilly, Virginia, US, has received the
Newsletter
Government Warns Against Misleading EdTech Platforms, Fake Universities
RHI Magnesita and Khemka Refractories Launch MINPRO Following Completion of Joint Venture
Tata Power Targets 30 Lakh Consumers for Rooftop Solar & Battery Storage by 2029
Ola Electric Signs MoU with Axis Energy to Expand Utility-Scale Energy Storage
ONGC Declares Q1 FY’27 Results; Net Profit Surges to ₹ 17,034 Cr
India Ratings Upgrades Transrail’s Long-Term Credit Rating to IND AA-; Outlook Stable